The BMG Labtech Omega family of multifunction microplate readers feature high resolution and full UV/visible spectrometer-based absorbance. This family of readers combines all of the speed, sensitivity and flexibility needed for life science applications and research.
Scientists have discovered the genome of a bacterial parasite incorporated into the genome of its host species, according to a report published recently in Science.
Scientists at the American Johns Hopkins University have now uncovered the mechanism the body uses to identify and remove errors in the genetic code, according to the prestigious scientific journal Nature.
University of Adelaide researchers have discovered a way of creating a male mouse without a Y chromosome by manipulating a single gene in the developing foetus.
Singaporean academics and industry have joined together to develop a rapid test for Hand, Foot and Mouth Disease (HFMD).
There is no doubt that genetic testing and the mapping of the human genome has changed the face of medicine, but it also raises new debates over ethics and, more importantly, who owns your genetic information?
Bosch Pharmaceutical has augmented its portfolio of vial filling solutions with the FLT1020, a system designed for increased efficiency in clinical trials. The filler is a downsized alternative to larger vial filling systems, specifically designed for the clinical/trials phase. Based on production technology, the FLT1020 minimises packaging and processing variables when shifting into the full scale production stage. Pharmaceutical firms moving from clinical trials to the production phase need to be able to predict how a drug will handle on the filling line and the FLT1020 addresses the demands of pharmaceutical manufacturers that require a scaled down unit that replicates the conditions of mass production. A smaller system enables firms to anticipate potential variables, streamline validation procedures and thus minimise the risks associated with scale up.
Three-stage procedures offer an optimal relationship between costs and benefits in analysing genetic influences in diseases and therapies, a fact that has major practical importance for the ever growing number of gene analyses.
An ambitious international effort has been launched to decode the genome of Eucalyptus, one of the world's most valuable fibre- and paper-producing trees - with the goal to maximise its potential in the burgeoning bio energy market and for capturing excess atmospheric carbon.
An automated test could enable population screening to identify carriers of the genetic disease fragile X syndrome (FXS), the most common inherited form of mental retardation, reports a study in the April issue of Genetics in Medicine, published by the American College of Medical Genetics and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Duke University Medical Center scientists have developed a genomic test to predict which patients with early-stage lung cancer will need chemotherapy to live and which patients can avoid the toxic regimen of drugs.
Researchers from Massachusetts Institute of Technology and Whitehead Institute have developed a cell culture test for assessing a compoundâ€™s genetic toxicity that may prove dramatically cheaper than existing animal tests. This assay would allow genetic toxicity to be examined far earlier in the drug development process.